External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension
L. Bianchi,F. Ceci,P. K-F. Chiu,F. Giganti,I. Heidegger,V. Kasivisvanathan,C. V. Kesch,G. Marra,A. Martini,J. Olivier,F. Preisser,P. Rajwa,K. Aas,U. G. Falagario,V. Fasulo,M. Maggi,I. Puche Sanz,M. C. Roesch,A. Sigle,T. Soeterik,L. F. Stolzenbach,J. G. Heetman,E. J. R. J. van der Hoeven,F. Zattoni,C. Kesch,S. Shariat,F. Dal Moro,G. Novara,G. La Bombara,F. Sattin,N. von Ostau,N. Pötsch,P. A. T. Baltzer,L. Wever,J. P. A. Van Basten,H. H. E. Van Melick,R. C. N. Van den Bergh,G. Gandaglia,T. F. W. Soeterik,on behalf of the European Association of Urology Young Academic Urologists Prostate Cancer Working Party,Board Members,Associates
DOI: https://doi.org/10.1038/s41391-023-00738-3
2023-11-07
Prostate Cancer and Prostatic Diseases
Abstract:Prediction of side-specific extraprostatic extension (EPE) is crucial in selecting patients for nerve-sparing radical prostatectomy (RP). Multiple nomograms, which include magnetic resonance imaging (MRI) information, are available predict side-specific EPE. It is crucial that the accuracy of these nomograms is assessed with external validation to ensure they can be used in clinical practice to support medical decision-making.
oncology,urology & nephrology